Sanofi-Aventis (France) Gets OK From U.S. Authorities For Apotex Corp. Bid

PARIS (Reuters) - France's Sanofi Aventis (SASY.PA) said on Wednesday that it had received the green light from U.S. antitrust regulators to take-over the U.S. biotech Genzyme (GENZ.O).

Back to news